Galmed Pharmaceuticals Ltd. buy Stifel Nicolaus
Start price
21.02.24
/
50%
€0.34
Target price
21.02.25
€59.19
Performance (%)
3.53%
Price
30.05.24
€0.35
Summary
This prediction is currently active. With a performance of 3.53%, the BUY prediction by Stifel_Nicolaus for Galmed Pharmaceuticals Ltd. is trending in the right direction. This prediction currently runs until 21.02.25. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | -0.565% | -0.565% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by Stifel_Nicolaus for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Stifel Nicolaus from $61.00 to $64.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.38
08.05.24
08.05.24
€65.08
08.05.25
08.05.25
-6.38%
30.05.24
30.05.24